retatrutide causing diarrhea More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide Constipation: Causes, Timeline &

At 48 weeks, mean percentage changes in body weight from baseline were approximately: In the 12 mg arm, roughly 100% of participants achieved at least 5% body-weight loss, about 83% reached 15% loss, around 63% achieved 20% loss, and approximately 26% crossed the 25% threshold

Robert Kushner, Professor of Medicine, Northwestern University Your healthcare provider will create a tailored plan for you

The science is more complex than the headline suggests, highlighting the importance of looking beyond headlines and interpreting the full evidence base

The GLP-1 component reaches a threshold level that produces noticeable changes in hunger patterns and food preferences

This stimulates the testes to produce more testosterone and more sperm

The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metabolism , 2008